Toro Neurovascular, Inc.

Toro Neurovascular is a medical device company specializing in advanced catheter technology for acute ischemic stroke intervention. The company develops and commercializes innovative aspiration thrombectomy devices designed to improve first-pass efficacy and reduce procedure times in large vessel occlusion (LVO) treatment. Their flagship product line includes the Toro™ 88 guide catheter and MicroFlex™ technology platform, which features reinforced catheters with enhanced flexibility for navigation through complex cerebrovascular anatomy. The MicroFlex™ design enables intuitive handling regardless of patient anatomy, allowing physicians to achieve higher intracranial positioning of large-bore (8F) catheters in the petrous segment and beyond. Clinical data demonstrates that elevated guide catheter positioning in aspiration thrombectomy correlates with higher first-pass effect rates and shorter procedure times. Toro Neurovascular targets interventional neuroradiology and neurosurgery practices focused on acute stroke care. The company is led by experienced medical device entrepreneurs with background in interventional catheter development, regulatory affairs, quality assurance, and global commercial operations. The organization addresses a significant clinical market: ischemic stroke affects 795,000+ patients annually in the United States and represents the leading cause of long-term disability worldwide, with an annual healthcare cost exceeding $104 billion.